The New EU Concentration Limits for Retinol in Cosmetics

Retinol has been one of the most requested actives in skincare for years, and it's also been quietly moving through EU regulatory attention because vitamin A compounds are a genuine total-exposure concern. People get vitamin A from diet, from supplements, and from cosmetics, and the EU's approach has been to cap the cosmetic contribution through Annex III of Regulation (EC) No 1223/2009 rather than leave it unrestricted just because it's a popular ingredient.

What's actually restricted

The Annex III framework covers vitamin A in its common cosmetic forms, and the relevant forms to know are retinol itself, retinyl acetate, and retinyl palmitate. These are three different INCI-named ingredients that all deliver vitamin A activity to the skin, and formulators sometimes use them interchangeably or in combination depending on stability and cost considerations in a given formula. Because they're functionally related, a maker using more than one of these forms in the same product needs to think about total vitamin A exposure across all of them, not just check each one individually against a limit as if they existed in isolation.

Why this is a concentration cap, not a ban

This is worth being clear about because it gets miscommunicated. Retinol is not prohibited in EU cosmetics. It's restricted, meaning it's permitted up to a specific concentration ceiling under Annex III, along with a required label warning tied to that use. That's a meaningfully different regulatory posture than an Annex II prohibited substance, which can't be used at all. If you're currently formulating with retinol at a level that was common practice before this Annex III entry existed, this is worth revisiting now rather than after your next batch is already labeled and boxed.

The label warning piece

Restricted substances under Annex III often carry a specific warning statement as part of the condition for permitted use, and retinol and its related esters are no exception. If your product falls under this Annex III entry, expect a required warning statement to accompany the concentration limit, meaning the compliance obligation isn't satisfied by concentration alone. Get the exact current wording from Annex III itself or from CosIng, since label warning language for restricted substances is typically specified precisely and isn't something to paraphrase from memory.

What to check in your own formula

• Identify every vitamin A ingredient in your formula by INCI name. Retinol, Retinyl Acetate, and Retinyl Palmitate are the three to look for specifically, and check any supplier blend documentation carefully, since some "vitamin A complex" or "retinol serum" pre-blends combine more than one of these.
• Calculate the actual finished-product concentration of each. If you're using a supplier's retinol blend at a given use level, multiply the blend's stated retinol percentage by your use level to get the real number, not the blend's own label concentration.
• Check the current Annex III entry or CosIng for the specific limit and warning wording that applies to your product type. Limits like this are exactly the kind of detail that's set by the regulation itself and can be revised, so verify against the current source rather than a number you remember from a past formulation.
• Update your label artwork alongside your formula, not after. If a warning statement is required, that's a labeling change that needs to ship with the reformulated product, not follow a version behind it.

A comparison worth keeping in mind

Ingredient	INCI name	Common role
Retinol	Retinol	Active vitamin A form, used directly
Retinyl acetate	Retinyl Acetate	Ester form, often more stable
Retinyl palmitate	Retinyl Palmitate	Ester form, common in lower-cost formulations

All three deliver vitamin A activity and all three sit under the same Annex III attention, even though they're chemically distinct ingredients with different CAS numbers and different typical use levels.

The practical bottom line

If retinol or its esters are anywhere in your EU-bound formula, this is worth a direct check against the current Annex III text or CosIng before you finalize a batch, not a "we'll deal with it later" item. Getting the concentration right and missing the warning statement is still an incomplete compliance picture.

Cosmetic Comply's EU module is on the way, and when it lands, checks like this, matching an ingredient to its Annex III status, calculating the real finished-product concentration through supplier blends, and flagging any required warning language, are exactly the kind of screening it's built to automate ahead of a Responsible Person's final review.